TITAN PHARMACEUTICALS INC — Director's Dealing 2014

Oct 14, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP.OB)
CIK: 0000910267
Period of Report: 2014-10-09

Reporting Person: Rubin Marc (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-09	Common Stock	P	100000	$0.482	Acquired	707200	Direct

Footnotes

F1: Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $0.47 to $0.49. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.